3 ms·
It makes me think about an idea that was heavily criticized in the beginning of the pandemic: to test vaccines in Africa. I remember a huge uproar: "we are not
by GuB-42 6y ago
It makes me think about an idea that was heavily criticized in the beginning of the pandemic: to test vaccines in Africa.
I remember a huge uproar: "we are not your guinea pigs". And I totally understand the sentiment. The vaccine will mostly benefit rich white people, while the poor Africans will, as always, get the short end of the stick. And I have no doubt it will happen like that.
But, by refusing trials in your poor country, you basically lower your chances of getting an effective vaccine when it matters from not much to zero. Allowing trials should be a good way to negotiate a way to secure doses for yourself, since you can't do it with money like first world countries. But it is also a way to have the vaccine tested on your population rather than only on white guys.
And sure, there are risks in doing that, but Covid-19 kills in Africa too. I didn't do a risk analysis but I am quite sure it is a net positive for the "guinea pig" countries.
And sure, in an ideal world, we should all work together and treat everyone independent of status and wealth in order to end the global pandemic as quickly as possible. But past events showed us it doesn't work like that. Rich countries fighting to secure resources (tests, masks, vaccines, ...) for themselves. The push for buying domestic products instead of from evil China. The very idea of evil China, partly justified but overblown for patriotic effect... Africa will get nothing but scraps unless they have a bargaining chip, and hosting vaccine trials could have been that chip.
- bsanr2 6y agoThe answer to your dilemma is in the premise: all these companies needed to do was to provide concrete assurances that the testing would net participants a spot in the front of the line and due compensation. That would mean spinning up resource supply chains and infrastructure to make sure not just testing, but actual administration, of the vaccine would happen there. But because of the neglect and exploitation much of Africa has experienced from major powers, that would have turned testing into a prohibitively funding- and time-intensive prospect. African leaders aren't stupid, they recognized that. So without those concrete assurances, any widespread testing would almost certainly have been yet another example of exploitation, where the spoils go north. And for what? Most African countries are dealing with COVID perfectly fine. Europe and America are the ones where the suffering is disproportionate to the norm. This is not a case of Africa suffering for its lack of desire to play ball with Western powers; it's one where Western powers killed hundreds of thousands of their own citizens unnecessarily. If there's any injustice, it's in that the people paying the price in our countries are the people who get screwed over by institutional neglect - sometimes, sabotage - time and again.
- phobosanomaly 6y agoChina is actually doing what you're describing with it's vaccine development. It's sort of a geopolitical power move for them, plus they don't have enough people domestically with the virus to run clinical trials anymore. As well, there's less of a potential PR-hangup for a Chinese company if they have to grease the local wheels with some cash 'donations,' whereas Pfizer and Moderna probably wouldn't want to be caught bribing people in the context of a clinical trial (I used to work for a Chinese immunodiagnostics company that did business in the developing world. It's just how things work some places if you want to enter a market and don't have the right political connections). It's not Africa-focused particularly, but they're running tons of clinical trials across the developing world, and will give these countries early-access that they would not otherwise have with the Western vaccines. https://www.sciencemag.org/news/2020/11/global-push-covid-19-vaccines-china-aims-win-friends-and-cut-deals https://www.sciencemag.org/news/2020/11/global-push-covid-19...